Lipocine earnings were -$4.1M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest LPCN earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$2.2M, down 27.7% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, LPCN reported annual earnings of -$16.4M, with 52% growth. The next LPCN earnings date is Mar 5, 2025.
On LPCN's earnings call on Invalid Date, Lipocine (NASDAQ: LPCN) reported Q3 2024 earnings per share (EPS) of -$0.41, up 67.46% year over year. Total LPCN earnings for the quarter were -$2.22 million. In the same quarter last year, Lipocine's earnings per share (EPS) was -$1.26.
The next LPCN earnings date is Invalid Date. Add LPCN to your watchlist to be reminded of Lipocine's next earnings date.
What was LPCN's earnings growth in the past year?
As of Lipocine's earnings date in Invalid Date, Lipocine's earnings has grown year over year. LPCN earnings in the past year totalled -$4.06 million.
Is Lipocine profitable or losing money?
As of the last Lipocine earnings report, Lipocine is currently losing money. Lipocine's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$4.06 million, a 75.12% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.